Search Results

There are 6444 results for: content related to: Symptom-relieving and neuroprotective effects of the phytocannabinoid Δ 9 -THCV in animal models of Parkinson's disease

  1. You have free access to this content
    Prospects for cannabinoid therapies in basal ganglia disorders

    British Journal of Pharmacology

    Volume 163, Issue 7, August 2011, Pages: 1365–1378, Javier Fernández-Ruiz, Miguel Moreno-Martet, Carmen Rodríguez-Cueto, Cristina Palomo-Garo, María Gómez-Cañas, Sara Valdeolivas, Carmen Guaza, Julián Romero, Manuel Guzmán, Raphael Mechoulam and José A Ramos

    Article first published online : 12 JUL 2011, DOI: 10.1111/j.1476-5381.2011.01365.x

  2. Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

    British Journal of Pharmacology

    Volume 172, Issue 3, February 2015, Pages: 737–753, John M McPartland, Marnie Duncan, Vincenzo Di Marzo and Roger G Pertwee

    Article first published online : 8 JAN 2015, DOI: 10.1111/bph.12944

  3. You have free access to this content
    The endocannabinoid system as a target for the treatment of motor dysfunction

    British Journal of Pharmacology

    Volume 156, Issue 7, April 2009, Pages: 1029–1040, Javier Fernández-Ruiz

    Article first published online : 13 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00088.x

  4. The therapeutic potential of cannabinoids for movement disorders

    Movement Disorders

    Volume 30, Issue 3, March 2015, Pages: 313–327, Benzi Kluger, Piera Triolo, Wallace Jones and Joseph Jankovic

    Article first published online : 4 FEB 2015, DOI: 10.1002/mds.26142

  5. Cannabinoid–dopamine interactions in the physiology and physiopathology of the basal ganglia

    British Journal of Pharmacology

    Concepción García, Cristina Palomo-Garo, Yolanda Gómez-Gálvez and Javier Fernández-Ruiz

    Article first published online : 31 JUL 2015, DOI: 10.1111/bph.13215

  6. You have free access to this content
    Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders

    CNS Neuroscience & Therapeutics

    Volume 16, Issue 3, June 2010, Pages: e72–e91, Javier Fernández-Ruiz, Mariluz Hernández and José A. Ramos

    Article first published online : 12 APR 2010, DOI: 10.1111/j.1755-5949.2010.00144.x

  7. You have free access to this content
    Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?

    British Journal of Clinical Pharmacology

    Volume 75, Issue 2, February 2013, Pages: 323–333, Javier Fernández-Ruiz, Onintza Sagredo, M. Ruth Pazos, Concepción García, Roger Pertwee, Raphael Mechoulam and José Martínez-Orgado

    Article first published online : 10 JAN 2013, DOI: 10.1111/j.1365-2125.2012.04341.x

  8. You have free access to this content
    Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes

    British Journal of Pharmacology

    Volume 163, Issue 7, August 2011, Pages: 1479–1494, Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott and Vincenzo Di Marzo

    Article first published online : 12 JUL 2011, DOI: 10.1111/j.1476-5381.2010.01166.x

  9. Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …

    Headache: The Journal of Head and Face Pain

    Volume 55, Issue 6, June 2015, Pages: 885–916, Eric P. Baron

    Article first published online : 25 MAY 2015, DOI: 10.1111/head.12570

  10. You have free access to this content
    The phytocannabinoid Δ9-tetrahydrocannabivarin modulates inhibitory neurotransmission in the cerebellum

    British Journal of Pharmacology

    Volume 154, Issue 1, May 2008, Pages: 204–215, Y-L Ma, S E Weston, B J Whalley and G J Stephens

    Article first published online : 29 JAN 2009, DOI: 10.1038/bjp.2008.57

  11. You have free access to this content
    The plant cannabinoid Δ9-tetrahydrocannabivarin can decrease signs of inflammation and inflammatory pain in mice

    British Journal of Pharmacology

    Volume 160, Issue 3, June 2010, Pages: 677–687, Daniele Bolognini, Barbara Costa, Sabatino Maione, Francesca Comelli, Pietro Marini, Vincenzo Di Marzo, Daniela Parolaro, Ruth A Ross, Lisa A Gauson, Maria G Cascio and Roger G Pertwee

    Article first published online : 22 MAR 2010, DOI: 10.1111/j.1476-5381.2010.00756.x

  12. Analysis of genomic variability in transgenic sugarcane plants produced by Agrobacterium tumefaciens infection

    Plant Breeding

    Volume 124, Issue 1, February 2005, Pages: 33–38, E. R. Carmona, A. D. Arencibia, J. Lopez, J. Simpson, D. Vargas and F. Sala

    Article first published online : 28 JUN 2008, DOI: 10.1111/j.1439-0523.2004.01021.x

  13. The phytocannabinoid, Δ9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects

    British Journal of Pharmacology

    Volume 172, Issue 5, March 2015, Pages: 1305–1318, Maria Grazia Cascio, Erica Zamberletti, Pietro Marini, Daniela Parolaro and Roger G Pertwee

    Article first published online : 13 FEB 2015, DOI: 10.1111/bph.13000

  14. You have free access to this content
    Effects of Δ9-tetrahydrocannabivarin on [35S]GTPγS binding in mouse brain cerebellum and piriform cortex membranes

    British Journal of Pharmacology

    Volume 154, Issue 6, July 2008, Pages: 1349–1358, I Dennis, B J Whalley and G J Stephens

    Article first published online : 29 JAN 2009, DOI: 10.1038/bjp.2008.190

  15. You have free access to this content
    Δ8-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB2 receptors

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2450–2461, Sándor Bátkai, Partha Mukhopadhyay, Bėla Horváth, Mohanraj Rajesh, Rachel Y Gao, Anu Mahadevan, Mukkanti Amere, Natalia Battista, Aron H Lichtman, Lisa A Gauson, Mauro Maccarrone, Roger G Pertwee and Pál Pacher

    Article first published online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01410.x

  16. You have free access to this content
    AM630 behaves as a protean ligand at the human cannabinoid CB2 receptor

    British Journal of Pharmacology

    Volume 165, Issue 8, April 2012, Pages: 2561–2574, Daniele Bolognini, Maria Grazia Cascio, Daniela Parolaro and Roger G Pertwee

    Article first published online : 23 MAR 2012, DOI: 10.1111/j.1476-5381.2011.01503.x

  17. You have free access to this content
    Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9-tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats

    British Journal of Pharmacology

    Volume 170, Issue 3, October 2013, Pages: 671–678, Erin M Rock, Martin A Sticht, Marnie Duncan, Colin Stott and Linda A Parker

    Article first published online : 17 SEP 2013, DOI: 10.1111/bph.12322

  18. You have free access to this content
    Δ9-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats

    Epilepsia

    Volume 51, Issue 8, August 2010, Pages: 1522–1532, Andrew J. Hill, Samantha E. Weston, Nicholas A. Jones, Imogen Smith, Sarah A. Bevan, Elizabeth M. Williamson, Gary J. Stephens, Claire M. Williams and Benjamin J. Whalley

    Article first published online : 26 FEB 2010, DOI: 10.1111/j.1528-1167.2010.02523.x

  19. You have free access to this content
    Synthetic and plant-derived cannabinoid receptor antagonists show hypophagic properties in fasted and non-fasted mice

    British Journal of Pharmacology

    Volume 156, Issue 7, April 2009, Pages: 1154–1166, Gernot Riedel, Paola Fadda, Susan McKillop-Smith, Roger G Pertwee, Bettina Platt and Lianne Robinson

    Article first published online : 17 FEB 2009, DOI: 10.1111/j.1476-5381.2008.00107.x

  20. Δ9-tetrahydrocannabinol (Δ9-THC) exerts a direct neuroprotective effect in a human cell culture model of Parkinson's disease

    Neuropathology and Applied Neurobiology

    Volume 38, Issue 6, October 2012, Pages: 535–547, C. B. Carroll, M.-L. Zeissler, C. O. Hanemann and J. P. Zajicek

    Article first published online : 17 SEP 2012, DOI: 10.1111/j.1365-2990.2011.01248.x